Euthyroid hyperthyroxinemia (original) (raw)

References

  1. Robbins J., Rail J.E. II. Hormone transport in circulation: interaction of thyroid hormones and proteins in biological fluids. Rec. Progr. Horm. Res. 13. 161, 1957.
    PubMed CAS Google Scholar
  2. Oppenheimer J.H. Role of plasma proteins in the binding, distribution and metabolism of thyroid hormones. N. Engl. J. Med. 278:1153, 1968.
    PubMed CAS Google Scholar
  3. Robbins J., Cheng S., Gershengorn M.C., Glinoer D., Cahmann H.J. Edelhoch H. Thyroxine transport proteins of plasma, molecular properties and biosynthesis. Rec. Progr. Horm. Res. 34: 477, 1978.
    PubMed CAS Google Scholar
  4. Dos Remedios L.V., Weber P.M., Feldman R., Schurr D.A., Tsoi T.G. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch. Intern. Med. 140: 1045, 1980.
    PubMed CAS Google Scholar
  5. Woeber K.A., Ingbar S.H. The contribution of thyroxine-binding pralbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest. 47: 1710, 1968.
    PubMed Central PubMed CAS Google Scholar
  6. Dowling J.T., Freinkel N., Ingbar S.H. Effect of diethylstibestrol on binding of thyroxine in serum. J. Clin. Endocrinol. Metab., 16: 1491, 1956.
    PubMed CAS Google Scholar
  7. Robbins J., Nelson J.H. Thyroxine binding by serum protein in pregnancy and in the newborn. J.Clin. Invest. 37: 153, 1958.
    PubMed Central PubMed CAS Google Scholar
  8. Galton V.A., Ingbar S.H., Jimenez-Fonesca J., Hershman J.M. Alterations in thyroid hormone economy in patients with hydatidiform mole. J.Clin. Invest. 50:1345, 1971.
    PubMed Central PubMed CAS Google Scholar
  9. Webster J.B., Coupai J.J., Cushman Jr. P. Increased serum thyroine levels in euthyroid narcotic addicts. J. Clin. Endocrinol. Metab. 37: 928, 1973.
    PubMed CAS Google Scholar
  10. Azizi F., Vagenakis A.G., Portnay G.I., Braverman L.E. Ingbar S.H. Thyroxine transport and metabolism in methadone and heroin addicts. Ann. Intern. Med. 80: 194, 1974.
    PubMed CAS Google Scholar
  11. Oltman J.E., Friedman S. Protein bound iodine in patients receiving perphenazine. JAMA 185:726, 1963.
    PubMed CAS Google Scholar
  12. Hollander C.S., Scott R.L., Tschudy D.P., Perlroth M., Maxman A., Sterling K. Increased protein bound iodine and thyroxine binding globulin in acute intermittent porphyria. N. Engl. J. Med., 227: 995, 1967.
    Google Scholar
  13. Kydd D.M., Man E.B. Precipitable iodine of serum (SPI) in disorders of the liver. J.Clin. Invest., 30: 874, 1951.
    PubMed Central PubMed CAS Google Scholar
  14. Vannotti A., Béraud T. Functional relationships between the liver, the thyroxine binding protein of serum and the thyroid. J. Clin. Endocrinol. Metab. 19: 466, 1959.
    PubMed CAS Google Scholar
  15. Schussler G.C., Schaffner F., Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N. Engl. J. Med., 299: 510, 1978.
    PubMed CAS Google Scholar
  16. Gardner D.F., Carithers Jr. R.L., Utiger R.D. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann. Intern. Med., 96: 450, 1982.
    PubMed CAS Google Scholar
  17. Beierwalts W.H., Robbins J. Familial incrase in thyroxine binding sites in serum alpha globulin. J. Clin. Invest. 38: 1683, 1959.
    Google Scholar
  18. Florsheim W.H., Dowling J.T., Meister L, Bodfish R.E. Familial elevation of serum thyroxine binding capacity. J. Clin. Endocrinol. Metab., 22: 735,1962.
    PubMed CAS Google Scholar
  19. Jones J.E., Seal U.S. X-chromosome linked inheritance of elevated thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 27:1521, 1967.
    PubMed CAS Google Scholar
  20. Refetoff S., Fang V.S., Marshall J.S., Robin N.I. Metabolism of thyroxine binding globulin in man: abnormal rate of synthesis in inherited thyroxine-binding globulin deficiency and excess. J.Clin. Invest. 57: 485, 1976.
    PubMed Central PubMed CAS Google Scholar
  21. Fex G., Adielsson G., Mattson W. Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol. (Kbh.) 97: 109, 1981.
    CAS Google Scholar
  22. Lever A., Bird D., Byfield P.G.H., Lalioz M.R.A., Webster A.D.B., Himsworth R.L. Increased serum concentration of T4-binding globulin in patients with hypogammaglobulinemia. Clin. Endocrinol. (Oxf.). 18: 195, 1983.
    PubMed CAS Google Scholar
  23. Ingbar S.H., Braverman L.E., Dawber N.A., Lee G.Y. A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J.Clin. Invest., 44: 1679, 1965.
    PubMed Central PubMed CAS Google Scholar
  24. Braverman L.E., Abreau C.M., Brock P., Kleinmann R., Fournier L, Odstrchel G., Schoemaker H.J.P. Measurement of serum free thyroxine by RIA in various, clinical states. J. Nucl. Med., 27:233, 1980.
    Google Scholar
  25. Chopra I.J., Van Herle A.J., Chua Teco G.N., Nguyen A.H. Serum free thyroxine in thyroidal and nonthyroidal illnesses: a comparison of measurements by radioimmunoassay, equilibrium dialysis and free thyroxine index. J. Clin. Endocrinol. Metab., 51: 135, 1980.
    PubMed CAS Google Scholar
  26. Glinoer D., McGuire R.A., Gershengorn M.C., Robbins J., Berman M. Effects of estrogen of thyroxine-binding globulin metabolism in rhesus monkeys. Endocrinology, 100:9: 1977.
    PubMed CAS Google Scholar
  27. Henneman G., Docter R., Krenning E.P., Bos G., Otten M., Visser T.J. Raised total thyroxine and free thyroxine inex but normal free thyroxine: a serum abnormality due to inherited increased affinity of iodothyronine for serum binding protein. Lancet, 7:639, 1979.
    Google Scholar
  28. Lee W.N.P., Golden M.P., Van Herle A.J., Lippe B.M., Kaplan S.A. Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J. Clin. Endocrinol. Metab. 49: 292, 1979.
    PubMed CAS Google Scholar
  29. Stockigt J.R., Topliss D.J., Barlow, White E.L., Hurley D.M., Taft P. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. J. Clin. Endocrinol. Metab., 53: 353, 1981.
    PubMed CAS Google Scholar
  30. Docter R., Bos G., Krenning E.P., Fekkes D., Visser T.J.. Hennemann G. Inherited thyroxine excess: a new serum abnormality due to an increased affinity for modified albumin. Clin. Endocrinol. (Oxf.). 15: 363, 1981.
    PubMed CAS Google Scholar
  31. Ruiz M., Rajatanavin R., Young R.A., Taylor C., Brown R., Braverman L.E., Ingbar S.H. Familial dysalbuminemic hyperthyroxinemia, a syndrome that can be confused with thyrotoxicosis. N. Engl. J. Med., 306: 635, 1982.
    PubMed CAS Google Scholar
  32. Borst G.C., Premachandra B.N., Burman K.D., Osburne R.C., Georges L.P., Johnsonbaugh R.E. Euthyroid familial hyperthyroxinemia due to abnormal thyroid hormone-binding protein. Am. J. Med., 73:283, 1982.
    PubMed CAS Google Scholar
  33. Barlow J.W., Csicsmann J.M., White E.L, Funder J.W., Stockigt J.R. Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin. J. Clin. Endocrinol. Metab., 55: 244, 1982.
    PubMed CAS Google Scholar
  34. Hennemann G., Bos G., Docter R. Familial inherited elevated serum thyroxine, caused by albumin with a higher affinity for thyroxine. Ann. Endocrinol. (Paris), 42: 34A, 1981 (abstract).
    Google Scholar
  35. Ruiz M., Taylor C., Young R., Rajatanavin R., Braverman L.E., Ingbar S.H. Studies of the syndrome of familial euthyroid isolated hyperthyroxinemia (EIH). Proceeding of the 57th Annual Meeting of the American Thyroid Association, Minneapolis, 1981, p. T-3 (abstract).
    Google Scholar
  36. White E.L., Barlow J.W., Burke C.W., Funder J.W., Stockigt J.R. A T4 loaded resin uptake system to detect familial euthyroid thyroxine excess. In: Stockigt J.R., Nagataki S. (Eds). Thyroid research VIII. Canberra, Australia, Australian Academy of Science, 1980, p. 513.
    Google Scholar
  37. Stockigt J.R., Degaris M., Csicsmann J., Barlow J.W., White E.L, Hurley D.M. Limitation of a newfree thyroxine assay (Amerlex® Free T4). Clin. Endocrinol. (Oxf) 15: 313,1981.
    CAS Google Scholar
  38. Stockigt J.R., DeGaris M., Barlow J.W. “Unbound analogue” methods for free T4: a note of caution. N.Engl. J. Med., 307:126, 1982.
    PubMed CAS Google Scholar
  39. Rajatanavin R., Fournier L, DeCosimo D., Abreau C., Braverman L.E. Elevated serum free thyroxine by thyroxine analog radioimmunoassays in euthyroid patients with familial dysalbuminemic hyperthyroxinemia. Ann. Intern. Med., 97: 865, 1982.
    PubMed CAS Google Scholar
  40. Jacobsson B., Petterson T., Sandstedt B., Carlsfrom A. Prealbumin in the islets of Langerhans. IRCS Med., Sci, 7: 590, 1979.
    CAS Google Scholar
  41. Moses A.C., Lawlor J., Haddow J., Jackson I. Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine binding prealbumin. N. Engl. J. Med., 306: 966, 1982.
    PubMed CAS Google Scholar
  42. Stockigt J.R., White E.L., Barlow J.W. Differences between familial hyperthyroxinemic syndrome. N. Engl. J. Med., 307: 824, 1982.
    PubMed CAS Google Scholar
  43. Moses A.C., Lawlor J., Haddow J., Jackson I. Differences between familial hyperthyroxinemic syndrome. N.Engl. J. Med., 307: 825, 1982.
    Google Scholar
  44. Robbins J., Rail J.E., Rawson R.W. An unusual instance of thyroxine-binding by human serum gamma globulin. J. Clin. Endocrinol. Metab., 16, 573, 1956.
    PubMed CAS Google Scholar
  45. Premachandra B.N., Blumenthal H.T. Abnormal binding of thyroid hormone in sera from patients with Hashimoto’s disease. J. Clin. Endocrinol. Metab., 27: 931, 1967.
    PubMed CAS Google Scholar
  46. Ikekubo K., Konishi J., Endo K., Nakajima K., Okuno T., Kasagi K., Mori T., Nagaka I., Torizuka K. Antityroxine and antitriiodothyronine antibodies in three cases of Hashimoto’s thyroiditis. Acta Endocrinol. (Kbh.). 89: 557,1978.
    CAS Google Scholar
  47. Staeheli V., Vallotton M.B., Burger A. Detection of human anti-thyroxine and anti-triiodothyronine antibodies in different thyroid conditions. J. Clin. Endocrinol. Metab., 41: 669, 1975.
    PubMed CAS Google Scholar
  48. Trimarchi F., Benvenga S., Fenzi G., Mariotti S., Consolo F. Immunoglobulin binding of thyroid hormones in a case of Waldenstrom’s macroglobulinemia. J. Clin. Endocrinol. Metab., 54:1045, 1982.
    PubMed CAS Google Scholar
  49. Wu S.Y., Green W. Triiodothyronine (T3) binding immunoglobulins in a euthyroid woman: Effects on measurement of T3 (RIA) and on T3 turnover. J. Clin. Endocrinol. Metab. 42: 642, 1976.
    PubMed CAS Google Scholar
  50. Ginsberg J., Segal D., Erlich R.M., Walfish P.G. Inappropriate triiodothyronine (T3) and thyroxine (T4) radioimmunoassay levels secondary to circulating thyroid hormone autoantibodies. Clin. Endocrinol. (Oxf.) 8: 133,1978.
    CAS Google Scholar
  51. Konishi J., Iida Y., Kousaka T., Ikekubo K., Nakagawa T., Torizuka K. Effect of anti-thyroxine autoantibodies on radioimmunoassay of free thyroxin in serum. Clin. Chem. 28: 1389, 1982.
    PubMed CAS Google Scholar
  52. Mullinger R.N., Walker G. Free thyroxine in thyroid disease. Clin. Chem. 28:1394, 1982.
    PubMed CAS Google Scholar
  53. Karlsson F.A., Wibell L, Wide L. Hypothyroidism due to thyroid hormone binding antibodies. N. Engl. J. Med. 296: 1146,1977.
    PubMed CAS Google Scholar
  54. Refetoff S., Dewind LT., De Groot L.J. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27: 279, 1967.
    PubMed CAS Google Scholar
  55. Weintraub B.D., Gershengorn M.C., Kourides I.A., Fein H. Inappropriate secretion of thyroid stimulating hormone. Ann. Intern. Med., 95: 339, 1981.
    Google Scholar
  56. Refetoff S., DeGroot L.J., Bernard B., Bewind L.T. Studies of a sibship with apparent hereditary resistance to intracellular action of thyroid hormone. Metabolism 21: 723, 1972.
    PubMed CAS Google Scholar
  57. Brooks M.H., Barbato A.L., Collins S., Garbincus J., Neidballa R.G., Hoffman D. Familial thyroid hormone resistance. Am. J. Med., 77:414, 1981.
    Google Scholar
  58. Bode H.H., Danon M., Weintraub B.D., Maloof F., Crawford J.D. Partial target organ resistance to thyroid hormone. J.Clin. Invest. 52: 776, 1973.
    PubMed Central PubMed CAS Google Scholar
  59. Lamberg B.A., Rosengard S., Leiwendahl K., Saarien P., Evered D.C. Familial partial peripheral resistance to thyroid hormones. Acta Endocrinol (Kbh.). 87: 303, 1978.
    CAS Google Scholar
  60. Liewendahl K. Triiodothyronine binding to lymphocytes from euthyroid subjects and a patient with peripheral resistance to thyroid hormone. Acta Endocrinol (Kbh.). 83: 64, 1976.
    CAS Google Scholar
  61. Liewendahl K., Rosengard S., Lamberg B.A. Nuclear binding of triiodothyronine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormones. Clin. Chem. Acta. 83:41, 1978.
    CAS Google Scholar
  62. Bemal J., Refetoff S., DeGroot L.J. Abnormality of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue reistance to thyroid hormone action. J. Clin. Endocrinol. Metab., 47: 1266, 1978.
    Google Scholar
  63. Kaplowitz P.B., D’Ercole J.A, Utiger R.D. Peripheral resistance to thyroid hormone in an infant. J. Clin. Endocrinol Metab., 53: 958, 1981.
    PubMed CAS Google Scholar
  64. Chait A., Kanter R., Green W., Kenny M. Defective thyroid hormone action in fibroblasts cultured from subjects with the syndrome of resistance to thyroid hormones. J. Clin. Endocrinol Metab., 54: 767, 1982.
    PubMed CAS Google Scholar
  65. Gershengorn M.C. Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone: A new syndrome of “inappropriate secretion of TSH”. J. Clin. Invest. 56: 633, 1975.
    PubMed Central PubMed CAS Google Scholar
  66. Kaplan M.M., Swartz S.L, Larsen P.R. Partial peripheral resistance to thyroid hormone. Am. J. Med., 50: 1115, 1981.
    Google Scholar
  67. Wartofsky L, Berman K.D. Alterations in thyroid function in patients with systemic illness: The “euthyroid sick syndrome”. Endocrin. Rev. 3: 164, 1982.
    CAS Google Scholar
  68. Kaptein L.M., Maclntyre S.S., Weiner J.M., Spencer C.A., Nicoloff J.T. Free thyroxine estimates in nonthyroidal illness: Comparison of eight methods. J. Clin. Endocrinol Metab., 52: 1073, 1981.
    PubMed CAS Google Scholar
  69. Chopra I.J., Chua Teco G.N., Nguyen A., Solomon D. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J. Clin. Endocrinol. Metab., 48: 63, 1979.
    Google Scholar
  70. Oppenheimer J.H., Schwartz H.L., Mariash C.N., Kaiser F.E. Evidence for a factor in the sera of patients with nonthy-roidal disease which inhibits iodothyronine binding by solid matrices, serum proteins and rat hepatocyte. J. Clin. Endocrinol. Metab., 54: 757, 1982.
    PubMed CAS Google Scholar
  71. Chopra I.J., Solomon D.H., Chua Teco G.N., Eisenberg J.B. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science, 275:407, 1982.
    Google Scholar
  72. Chopra I.J., Solomon D.H., Hepner G.W., Morgenstein A.A. Misleading low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann. Intern. Med., 90: 905, 1979.
    PubMed CAS Google Scholar
  73. Bacci V., Schussler G.C., Kaplan T.B. The ralationship between serum triodothyronine and thyrotropin during systemic illness. J. Clin. Endocrinol. Metab., 54: 1229, 1972.
    Google Scholar
  74. Gavin L.A., Rosenthal M., Cavalieri R.R. The diagnostic dilemma of isolated hyperthyroxinemia in acute illness. JAMA 242: 251, 1979.
    PubMed CAS Google Scholar
  75. Burrows A.W., Shakesper R.A., Hesch R.D., Cooper E., Aicken C.M., Burke C.W. Thyroid hormones in elderly sick: “T4 euthyroidism”. Br. Med. J. 4: 437, 1975.
    PubMed Central PubMed CAS Google Scholar
  76. Britton K.E., Quinn V., Ellis S.M., Miralles J.M., Quinn V., Cayley A.C.D., Brown B., Ekins R.P. Is “T4 a normal biochemical finding in elderly women? Lancet 2: 141, 1975.
    PubMed CAS Google Scholar
  77. Gooch B.R., Isley W.L, Utiger R.D. Abnormalities in thyroid function tests in patients admitted to a medical service. Arch. Intern. Med. 142: 1801, 1982.
    PubMed CAS Google Scholar
  78. Turner T.G., Brownlie B.E.W., Sadder W.A. Does T4 toxicosis exist? Lancet 7: 407, 1975.
    Google Scholar
  79. Caplan R.H., Pagliara A.S., Wickus G. Thyroxine thyrotoxicosis a common variant of hyperthyroidism. JAMA 17: 1934, 1980.
    Google Scholar
  80. Birkhauser M., Busset R., Burer T., Burger A. Diagnosis of hyperthyroidism when serum thyroxine alone is raised. Lancet 2: 53, 1977.
    PubMed CAS Google Scholar
  81. Engler D., Donaldson E.B., Stockigt J.R., Taft P. Hyperthyroidism without triiodothyronine excess: An effect of severe non-thyroidal illness. J. Clin. Endocrinol. Metab. 46: 77, 1978.
    PubMed CAS Google Scholar
  82. Maturlo S.J., Rosenbaum R.L, Pan C., Surks MI. Variable thyrotropin response to thyrotropin releasing hormone after small decrease in plasma free thyroid hormone concentrations in patients with nonthyroidal disease. J.Clin. Invest., 66:451, 1980.
    PubMed Central PubMed CAS Google Scholar
  83. Whybrow P.C., Prange A.J., Treadway C.K. Mental changes accompanying thyroid gland dysfunction. Arch. Gen. Psych., 20: 48, 1969.
    CAS Google Scholar
  84. McLarty D.G., Ratcliffe W.A., Ratcliffe J.G., Shimmins J.G., Goldberg A. A study of thyroid function in psychiatric in-patients. Br. J. Psych. 733:211, 1978.
    Google Scholar
  85. Whybrow P.C., Coppen A., Prange A.J., Noguerra R., Bailey J.E. Thyroid function and the response to liothyronine in depression. Arch. Gen. Psych. 26: 242, 1972.
    CAS Google Scholar
  86. Goldberg I.J.L, Lawton K., Ridges A.P. The effect of depression and its treatment on serum thyroxine. Post Grad. Med. J. 53: 211, 1977.
    CAS Google Scholar
  87. Kirkegaard C., Faber J. Altered serum levels of thyroxine, tri-iodothyronines and diidothyronines in endogenous depression. Acta Endocrinol (Kbh.). 86: 199, 1981.
    Google Scholar
  88. Pecknold J.C., Ban T.A., Lehmann H.E., Nair N.P.V., Orbach L. Thyrotropin releasing hormone in depression: Clinical and endocrinological findings. Psycho Pharmac. Bull., 14: 44, 1976.
    Google Scholar
  89. Cohen L.K., Swigar M.E. Thyroid function screening in psychiatric patients. JAMA, 242: 254, 1979.
    PubMed CAS Google Scholar
  90. Spratt D.I., Pont A., Miller M.B., McDougall I.R., Bayer M.F., McLaughlin W.T. Hyperthyroxinemia in patients with acute psychiatric disorders. Am. J. Med., 73:41, 1982.
    PubMed CAS Google Scholar
  91. Brunn T., Kristoffersen K. Thyroid function during pregnancy, with special reference to hydatidiform mole and hyperemesis. Acta Endocrinol. (Kbh.), 88: 383, 1978.
    Google Scholar
  92. Bouillon R., Naesens M., Van Assche Thyroid function in patients with hyperemesis gravidarum. Am. J. Obstet. Gynectol., 143: 922, 1982.
    CAS Google Scholar
  93. Kenimer J.G., Hershman J.M., Higgens P.M. The thyrotropin in hydatidiform moles in human chorionic gonadotropin. J. Clin. Endocrinol. Metab., 40: 482, 1975.
    PubMed CAS Google Scholar
  94. Fairweather D.V.I. Nausea and vomitting in pregnancy. Am. J. Obstet. Gynecol. 102: 135,1968.
    PubMed CAS Google Scholar
  95. Cavalieri R.R., Pitt-Rivers R. The effects of drugs on the distribution and metabolism of thyroid hormones. Pharm. Rev., 32: 55, 1981.
    Google Scholar
  96. Bürgi H., Wimpheimer C., Burger A., Zaunbauer W., Rosier H., Lemarchand-Béraud T. Changes of circulatory thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J. Clin. Endocrinol., Metab., 43: 1203, 1976.
    Google Scholar
  97. Kleinmann R.E., Vagenakis A.G., Braverman L.E. The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects. J. Clin. Endocrinol. Metab. 51: 399, 1980.
    PubMed CAS Google Scholar
  98. Larsen P.R., Dick T.E., Markovitz B.P., Kaplan M.M., Gard T.G. Inhibition of intrapituitary thyroxine to 3,5, 3′-triiodo-thyronine conversion prevents the acute suppression of thyrotropin released by thyroxine in hypothyroid rats. J.Clin. Invest. 64:117, 1979.
    PubMed Central PubMed CAS Google Scholar
  99. Obregon M.J., Pascual A., Mallol J., Morreale de Escobar G., Escobar Del Rey F. Evidence against a major role of L-thyroxine at the pituitary level: Studies in rats treated with iopanoic acid (Telepaque). Endocrinology 106: 1827, 1980.
    PubMed CAS Google Scholar
  100. Felicetta J.V., Green W.L, Nelp W.B. Inhibition of hepatic binding of thyroxine by cholecystographic agents J.Clin. Invest., 65:1032, 1980.
    PubMed Central PubMed CAS Google Scholar
  101. Larsen P.R. Thyroid-pituitary interaction: Feedback regulation of thyrotropin secretion by thyroid hormone. N.Engl. J. Med. 306: 23, 1982.
    PubMed CAS Google Scholar
  102. Kleinmann R.E., Sternthal E., Starobin O., Braverman LE. Cardiac catheterization dye does not affect serum thyroid hormone concentrations or TSH secretion. Cath. Card. Diag. 8:261, 1982.
    CAS Google Scholar
  103. Fairhurst B.J., Nagui N. Hyperthyroidism after cholecystography. Br. Med. J., 3:630, 1975.
    PubMed Central PubMed CAS Google Scholar
  104. Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Béraud T., Vallotton M.B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin and thyrotropin. A drug influencing peripheral metabolism of thyroid hormone. J. Clin. Invest., 58: 255, 1976.
    PubMed Central PubMed CAS Google Scholar
  105. Melmed S., Nademanee K., Reed A.W., Hendrickson J.A., Singh B.N., Hershman J.M. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J. Clin. Endocrinol. Metab., 53: 997, 1981.
    PubMed CAS Google Scholar
  106. Jonckheer M.H., Blockx P., Kaivers R., Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol (Brux). 28: 192, 1973.
    CAS Google Scholar
  107. Jonckheer M.H., Blockx P., Broeckaer I., Cornette C., Beckers C. “Low T3, syndrome” in patients chronically treated with an iodine-containing drug, amiodarone. Clin. Endocrinol. (Oxf)., 9: 27, 1978.
    PubMed CAS Google Scholar
  108. Bekaert J., Solvay H., Van Schepdael J. Etude de l’effect de l’amiodarone sur la fonction thyroidienne. Coeur Med. Interne, 18: 241, 1979.
    PubMed CAS Google Scholar
  109. Damgaard Anderson E. Long-term antiarrhythmic therapy with amiodarone. High prevalence of thyrotoxicosis (11%). Eur. Hearth J. 2(Suppl A): 199, 1981.
    Google Scholar
  110. Borghi A., Bassi F., Gheri R.G. Endocrinological aspects of long-term amiodarone treatment in arrhythmic patients. In: Abstract Book, Le nuove frontière délie aritmie (seminar), Marilleva (Italy), 1982, p. 74.
    Google Scholar
  111. Chevigne-Brancard M., Vandalem J.L. Thyroid function during and after amiodarone therapy. Proceeding of the 64th Annual Meeting of the Endocrine Society, San Francisco, 1982, p. 111 (abstract).
    Google Scholar
  112. Jaggarao N.S.V., Sheldon J., Grundy E.N., Vincent R., Chamberlain D.A. The effects of amiodarone on thyroid function. Post Grad. Med. J., 58:693, 1982.
    CAS Google Scholar
  113. Jonckheer M.H. Amiodarone and thyroid gland — a review. Acta Cardiol. (Brux). 36: 199, 1981.
    CAS Google Scholar
  114. Morley J.E., Shafer R.B., Elson M.K., Flag M.L., Raleigh M.J., Brammer G., Yuwiler A., Hershman J. Amphetamine-induced hyperthyroxinemia. Ann. Intern. Med., 93:707, 1980.
    PubMed CAS Google Scholar
  115. Hollander C.S., Scott R.L., Burgess J.A., Rabinowitz D., Mérimée T.J., Oppenheimer J.H. Free fatty acids: A possible regulation of free thyroid hormone levels in man. J. Clin. Endocrinol. Metab., 27: 1219, 1967.
    PubMed CAS Google Scholar
  116. Schatz D.L., Sheppard R.H., Steiner G., Chandarlapaty C.S., De Vebur G.A. Influence of heparin on serum free thyroxine. J. Clin. Endocrinol. Metab., 29: 1015, 1969.
    PubMed CAS Google Scholar
  117. Hershman J.M., Jones C.M., Bailey A.L. Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin J. Clin. Endocrinol Metab., 34: 574, 1972.
    Google Scholar
  118. Schwartz H.I., Schadlow A.R., Faierman D., Surks M.I., Oppenheimer J.H. Heparin administration appears to decrease cellular binding of thyroxine. J. Clin. Endocrinol. Metab., 36: 598, 1973.
    PubMed CAS Google Scholar
  119. Boss M., Kingstone D., Chang M.K., Varghese Z. Contradictory findings in the measurements of free thyroxine after administration of heparin. Clin. Chem., 28: 1238, 1982.
    PubMed CAS Google Scholar
  120. Lundberg P.A., Jagenburg K., Lindstedt G., Nystrom E. Heparin in vivo effect on free thyroxine. Clin. Chem., 28: 1241, 1982.
    PubMed CAS Google Scholar
  121. Shanks R.B., Hadden D.R., Lowe D.C., McDermitt D.G., Montgomery D.A.D. Control trial of propranolol in thyrotoxicosis. Lancet, 7:993, 1969.
    Google Scholar
  122. Harrower A.D.B, Fyffe J.A., Horn D.B., Strong J.A. Thyroxine and triiodothyronine levels in hyperthyroid patients during tratment with propranolol. Clin. Endocrinol. (Oxf.) 7: 41, 1977.
    CAS Google Scholar
  123. Verhoeven R.P., Visser T.J., Docter R., Hennemann G., Schalekamp M.A.D.H. Plasma thyroxine, 3,3′, 5-triiodothyronine and 3,3′, 5-triiodo-thyronine during β-adrenergic blockade in hyperthyroidism. J. Clin. Endocrinol. Metab. 44: 1002, 1977.
    PubMed CAS Google Scholar
  124. Wiersinga W.M., Touber J.L. The influence of β-adrenoreceptor blocking agents on plasma thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab., 45: 293, 1977.
    PubMed CAS Google Scholar
  125. Cooper D.S., Daniels G.H., Ladenson P.W., Ridgway E.C. Hyperthyroxinemia in patients treated with high-dose propranolol. Am. J. Med., 73:867, 1982.
    PubMed CAS Google Scholar
  126. Heyma P., Larkins R.G., Campbell D.G. Inhibition by propranolol of 3,5,3′ triiodothyroxine formation from thyroxine in isolated rat renal tubules: An effect independent of β-adrenergic blockade. Endocrinology, 106: 1437, 1980.
    PubMed CAS Google Scholar
  127. Perrild H., Molholm Hansen J., Skovsted L, Korsgaard Christensen L. Different effects of propranolol, alprenolol, Sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin. Endocrinol. (Oxf.) 18: 139, 1983.
    CAS Google Scholar
  128. Braverman L.E., Vagenakis A.G., Downs P., Foster A.E., Sterling K., Ingbar S.H. Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J. Clin. Invest., 52: 1010, 1973.
    PubMed Central PubMed CAS Google Scholar
  129. Stock J.M., Surks M.I., Oppenheimer J.H. Replacement dosage of L-thyroxine in hypothyroidism: a re-evaluation. N.Engl. J. Med., 290: 529, 1974.
    PubMed CAS Google Scholar
  130. Saberi M., Utiger R.D. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J. Clin. Endocrinol. Metab., 39: 923, 1974.
    PubMed CAS Google Scholar
  131. Kahn A. Serum thyroxine levels in patients reveiving L-thyroxine suppression or replacement therapy. Can. Med. Assoc. J. 109: 279, 1973.
    PubMed Central PubMed CAS Google Scholar
  132. Wong M.M., Volpè R. What is the best for monitoring level of thyroxine therapy? Can. Med. Assoc. J. 124: 1181, 1981.
    PubMed Central PubMed CAS Google Scholar
  133. Ingbar J.C., Borges M., Iflash S., Kleinmann R.E., Braverman L.E., Ingbar S.H. Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxine. J. Endocrinol. Invest. 5: 77, 1982.
    PubMed CAS Google Scholar
  134. Lo Presti J.S., Warren D.W., Kaptein E.M., Croyson M.J., Nicoloff J.T. Urinary immunoprecipitation method for estimation of thyroxine to triiodothyronine conversion in altered thyroid states. J. Clin. Endocrinol. Metab. 55: 666, 1982.
    CAS Google Scholar
  135. Brown M.E., Refetoff S. Transient elevation of serum thyroid hormone concentration after initiation of replacement therapy in myxedema. Ann. Intern. Med., 92: 491, 1980.
    PubMed CAS Google Scholar
  136. Greene R., Ferran H.E. The physiological activity of D-thyroxine. Br. Med. J. 2: 1057, 1958.
    PubMed Central PubMed CAS Google Scholar
  137. Oliver M.F., Boyd G.S. Reduction of serum cholesterol by dextro thyroxine in men with coronary heart disease. Lancet, 7:783, 1961.
    Google Scholar
  138. Gorman C.A., Jiang N.S., Ellefson R.D., Elveback L.R. Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients. J. Clin. Endocrinol. Metab., 49: 1, 1979.
    PubMed CAS Google Scholar
  139. Bantle J.P., Oppenheimer J.H., Schwartz H.L., Hunninghake D.B., Propbsfield J.L., Hanson R.F. TSH response to TRH in euthyroid, hypercholestero-lemic patients treated with graded dose of dextrothyroxine. Metabolism., 30:63, 1981.
    PubMed CAS Google Scholar
  140. Leb G., Lankmayer F.P., Goebel R., Pristautz H., Nachtmann F., Knapp G. Stereospecific determination of D-thyroxin and L-thyroxin in serum. Klin. Wochenschr. 59: 861, 1981.
    PubMed CAS Google Scholar
  141. Surks M.I. Elevated PBI, free thyroxine, and plasma protein concentration in man at high altitude. J. Appl., Physiol., 27: 1185, 1966.
    Google Scholar
  142. Kotchen T.A., Mongey E.H., Hogan K.P., Boyd III A.E., Pennington L.L., Mason J.W. Thyroid response to simulated altitude. J. Appl. Physiol. 34: 165, 1973.
    PubMed CAS Google Scholar
  143. Rastogi G.K., Malhotra M.S., Srivastava M.C., Sawhney R.C., Dua G.L., Sridharan K., Hoon R.S., Singh I. Study of the pituitary-thyrodi functions at high altitude in man. J. Clin. Endocrinol. Metab., 44: 447, 1977.
    PubMed CAS Google Scholar
  144. Mordes J.P., Blume F.D., Boyer S., Zheng M., Braverman L.E. Pituitary-thyroid physiology on Mt. Everest. Proceedings of the 58th Annual Meeting of the American Thyroid Association, Quebec City, 1982, p. 7 (abstract).
    Google Scholar

Download references